EMC1 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-05171
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Format
BSA Free
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 885-965 of human EMC1 (NP_055862.1). IPTEQSREENLIPYSPDVQIHAERFINYNQTVSRMRGIYTAPSGLESTCLVVAYGLDIYQTRVYPSKQFDVLKDDYDYVLI
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for EMC1 Antibody - BSA Free
Western Blot: EMC1 AntibodyBSA Free [NBP3-05171]
Western Blot: EMC1 Antibody [NBP3-05171] - Analysis of extracts of various cell lines, using EMC1 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic KitApplications for EMC1 Antibody - BSA Free
Application
Recommended Usage
Immunohistochemistry
1:100-1:200
Western Blot
1:500-1:2000
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS with 50% glycerol, pH7.3.
Format
BSA Free
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: EMC1
Alternate Names
hypothetical protein LOC23065, KIAA0090, RP1-43E13.1
Gene Symbol
EMC1
Additional EMC1 Products
Product Documents for EMC1 Antibody - BSA Free
Product Specific Notices for EMC1 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...